Biotech

All Articles

Lykos 'remorses' not making known research violations with publisher

.Psychopharmacology has actually pulled 3 posts concerning midstage medical trial information determ...

Analysts dig into Avidity's DMD succeed, disclosing subtleties in data

.Avidity Biosciences impressed entrepreneurs with period 1/2 information in Duchenne muscular dystro...

Actinogen's cortisol blocker stops working phase 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually skipped the main endpoint of a stage 2 research s...

Bivictrix makes a decision going private only means to take ADC into medical clinic

.Antibody-drug conjugates (ADCs) have gone to the center of several a billion-dollar biobuck licensi...

TPG tops up funds to $580M for assets across lifestyle scientific researches

.Property supervisor TPG, which has sustained biotechs such as Sionna Therapies and also Santa Ana B...

Merck quits period 3 TIGIT test in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT program has suffered an additional obstacle. Months after shuttering a stage...

After a hard year, Exscientia folds right into Recursion

.After a year defined by pipeline cuts, the departure of its own chief executive officer as well as ...

Cullinan, after $25M deal, hands back bispecific to Port

.Cullinan Therapy was blown away good enough with Port BioMed's bispecific immune reactor that it en...

A closer check out Fierce Biotech's Intense 15

.In this week's episode of "The Leading Pipe," our company are actually diving into Strong Biotech's...

Lilly faces phase 2 breakdown of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's gathering celebrating the commendatio...